Showing 341 - 360 results of 2,136 for search '"Cell Death ', query time: 0.07s Refine Results
  1. 341

    Advanced Applications of Fuel Cells during the COVID-19 Pandemic by Shammya Afroze, Md Sumon Reza, Quentin Cheok, Shafi Noor Islam, Abdalla M. Abdalla, Juntakan Taweekun, Abul K. Azad, Nima Khalilpoor, Alibek Issakhov

    Published 2021-01-01
    “…These makeshift hospitals need an uninterrupted power supply to continuously maintain all the electrical facilities. Fuel cells, especially solid oxide fuel cells, play an essential role in meeting the additional energy needs of humankind during this critical moment. …”
    Get full text
    Article
  2. 342
  3. 343
  4. 344

    Secretion of One Adipokine Nampt/Visfatin Suppresses the Inflammatory Stress-Induced NF-κB Activity and Affects Nampt-Dependent Cell Viability in Huh-7 Cells by Yi-Ching Lin, Hui-Chung Wu, Chen-Chung Liao, Yi-Chih Chou, Shwu-Fen Pan, Chi-Ming Chiu

    Published 2015-01-01
    “…We found that the transition of Nampt/visfatin from intracellular into extracellular form was induced by H2O2 treatment in 293T cells and confirmed that this phenomenon was not due to cell death but through the secretion of Nampt/visfatin. …”
    Get full text
    Article
  5. 345

    Inhibition of the anti-apoptotic protein BCL2 in EML4-ALK cell models as a second proposed therapeutic target for non-small cell lung cancer. by Richard Junior Zapata Dongo, Diletta Fontana, Luca Mologni, Juan Enrique Faya Castillo, Stefany Fiorella Infante Varillas

    Published 2025-01-01
    “…On the other hand, overexpression of BCL2, a protein involved in cell death regulation, has been observed in NSCLC and is considered a potential therapeutic target. …”
    Get full text
    Article
  6. 346
  7. 347

    Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells agains... by Weiting Liao, Ge Gao, Xia He, Pei Shu, Qizhi Ma, Benxia Zhang, Diyuan Qin, Yongsheng Wang

    Published 2023-08-01
    “…We have applied RNA sequencing, flow cytometry, ELISA, cellular/molecular immunological technology, and mouse models of solid cancers.Results Our study provided evidence that S1PR3 high expression is positively associated with resistance to programmed cell death protein-1 (PD-1)-based immunotherapy and increased T-cell exhaustion. …”
    Get full text
    Article
  8. 348

    Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells by Nadia Gabellini, Valentina Masola

    Published 2009-01-01
    “…HeLa cell clones stably expressing LGI1 exhibited a significant impairment of proliferation and a consistent increase of cell death when compared with control cells lacking expression of LGI1. …”
    Get full text
    Article
  9. 349
  10. 350

    Chronic Gastroesophageal Reflux Dysregulates Proteostasis in Esophageal Epithelial CellsSummary by Kodisundaram Paulrasu, Ravindran Caspa Gokulan, Wael El-Rifai, Zhibin Chen, Jianwen Que, Timothy C. Wang, Olivier G. Boutaud, Karoline Briegel, Sergey I. Dikalov, Monica T. Garcia-Buitrago, Alexander I. Zaika

    Published 2025-01-01
    “…Dysregulation of proteostasis induces ferroptotic cell death and is mediated by modification of cellular proteins with reactive isoLGs that can be prevented by isoLG scavengers. …”
    Get full text
    Article
  11. 351

    Prognostic Value of Endothelial Progenitor Cells in Acute Myocardial Infarction Patients by Gongjie Ye, Xiaodan Chen, Yinchao Zhou, Jianqing Zhou, Yongfei Song, Xiaoyong Yang, Lei Yang

    Published 2023-01-01
    “…The counts of EPCs were found to be significantly higher in the survival group compared to the death group (P<0.05). In the univariate analysis, it was observed that the 28-days mortality rate was associated with the several factors, including the APACHEⅡscore (P=0.00), vasoactive inotropic score (P=0.03), GAP (P=0.00), HCY (P=0.00), creatinine (P=0.00), C-reactive protein (P=0.00), HbAlc (P=0.00), CI (P=0.01), quartiles of CD34+/CD133+ cells (P=0.00), and quartiles of CD34+/CD133+/KDR+ cells (P=0.00). …”
    Get full text
    Article
  12. 352

    Resveratrol Sensitizes Selectively Thyroid Cancer Cell to 131-Iodine Toxicity by Seyed Jalal Hosseinimehr, Seyed Amir Hossein Hosseini

    Published 2014-01-01
    “…Findings of this study show that resveratrol enhanced the cell death induced by 131I on thyroid cancer cell. …”
    Get full text
    Article
  13. 353

    The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment by Manuel Varas-Godoy, Gregory Rice, Sebastián E. Illanes

    Published 2017-01-01
    “…These properties are associated with the capacity of CSCs to interact with different cells of the tumor microenvironment including mesenchymal stem cells, endothelial cells, immune cells, and fibroblasts, promoting cancer progression. …”
    Get full text
    Article
  14. 354

    The deregulated physiology in oral squamous cell carcinoma- a brief review by Keerthika Saravanan, Madhu Narayan, Krishnan Rajkumar

    Published 2024-06-01
    “…In cancer biology, hallmarks of cancer represent the normal physiology gone astray such as sustaining proliferative signaling, evading growth suppressors, avoiding immune destruction, activating invasion and metastasis, tumor promoting inflammation, enabling replicative immortality, inducing angiogenesis and resisting cell death that thus serve as blueprints for understanding core cancer characteristics. …”
    Get full text
    Article
  15. 355

    Contribution of long-lived plasma cells to antibody-mediated allograft rejection by Eunkyeong Jang, Jeehee Youn

    Published 2024-12-01
    “…However, accumulating evidence indicates that LLPCs, unlike conventional short-lived plasma cells, can respond to extrinsic signals from their survival niches and can resist cell death associated with intracellular stress through cell-intrinsic mechanisms. …”
    Get full text
    Article
  16. 356

    Mechanisms Underlying the Osteo- and Adipo-Differentiation of Human Mesenchymal Stem Cells by Yu Zhang, Dilaware Khan, Julia Delling, Edda Tobiasch

    Published 2012-01-01
    “…Human mesenchymal stem cells (hMSCs) are considered a promising cell source for regenerative medicine, because they have the potential to differentiate into a variety of lineages among which the mesoderm-derived lineages such adipo- or osteogenesis are investigated best. …”
    Get full text
    Article
  17. 357

    Adenocarcinoma with Neuroendocrine Differentiation of the Colon Accompanying Osteoclast-Like Giant Cells by Mitsuhiro Tachibana, Tadahiro Isono, Yutaka Tsutsumi

    Published 2020-01-01
    “…CD8/granzyme B-positive tumor-infiltrating lymphocytes and CD163/CD68-positive macrophages, frequently forming OGCs, were observed particularly at the invasion front. The carcinoma cells were labeled focally for synaptophysin and diffusely for the DR locus of the human leukocyte antigen and programmed death-ligand 1 (PD-L1). …”
    Get full text
    Article
  18. 358

    Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells by Eleftheria Tsakalozou, Allison M. Eckman, Younsoo Bae

    Published 2012-01-01
    “…Equipotent drug combination treatments (7×7) revealed that the DOC/DOX combination leads to high synergy and effective cell death only in a narrow concentration range in DU145. …”
    Get full text
    Article
  19. 359

    Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition by Aimin Yang, Xia Xiao, Mingfeng Zhao, Amanda C. LaRue, Bradley A. Schulte, Gavin Y. Wang

    Published 2015-01-01
    “…Although bone marrow (BM) suppression is one of the primary side effects of anticancer drugs, it is not known if pharmacological inhibition of dual mTORC1/2 affects BM hematopoietic stem and progenitor cells (HSPCs) function and plasticity. Here we report that dual inhibition of mTORC1/2 by AZD or its analogue (KU-63794) depletes mouse BM Lin−Sca-1+c-Kit+ cells in cultures via the induction of apoptotic cell death. …”
    Get full text
    Article
  20. 360

    Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells by Hidehito Saito, Keisuke Okita, Noemi Fusaki, Michael S. Sabel, Alfred E. Chang, Fumito Ito

    Published 2016-01-01
    “…Tumor-infiltrating lymphocytes (TILs) that express programmed cell death protein-1 (PD-1) are tumor-reactive T cells, and adoptive cell therapy with autologous TILs has been found to achieve durable complete response in selected patients with metastatic melanoma. …”
    Get full text
    Article